FindTrial
Sign In

Expanded Access Program (EAP) STIMULAN VG

Expanded Access Program (EAP) STIMULAN VG

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06808568
Acronym
EAPSTIMVG
Enrollment
Unknown
Registered
2025-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IV Pressure Ulcer, Diabetic Foot Osteomyelitis

Brief summary

Individual (single) patient expanded access may be considered.

Detailed description

Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers. Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient. Please contact expandedaccess@biocomposites.com for more information.

Interventions

COMBINATION_PRODUCTSTIMULAN VG

Sponsors

Biocomposites Ltd
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

Primary ContactBiocomposites Expanded Access Team
expandedaccess@biocomposites.com+44 (0) 1782 338 580

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026